Publications by authors named "Michael Cecchini"

Claim this Profile
P
Personalized risk assessment of frailty in long-term cancer survivors.
Rebecca Forman, Sarah J Westvold, Jessica B Long, Jane Fan, Terry Hyslop, Michael Cecchini

J Geriatr Oncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accuracy of Computed Tomography Staging of Mismatch Repair-Deficient Colon Cancer.
Samantha M Linhares, Thejal Srikumar, Clifford Shin, Mahan Mathur, Abedalrazaq Alkukhun, Michael Cecchini

JCO Oncol Pract· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Late-Onset Depression in Long-Term Survivors of Breast, Prostate, and Colorectal Cancer.
Melissa Taylor, Sarah J Westvold, Jessica B Long, Terry Hyslop, Andrea Silber, Michael Cecchini

JAMA Netw Open· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic and Epigenomic ctDNA Profiling in Liquid Biopsies from Heavily Pretreated Patients with DNA Damage Response-Deficient Tumors.
Ian M Silverman, Joseph D Schonhoft, Benjamin Herzberg, Arielle Yablonovitch, Errin Lagow, Michael Cecchini

Clin Cancer Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High MGMT expression identifies aggressive colorectal cancer with distinct genomic features and immune evasion properties.
Janie Yue Zhang, Barani Kumar Rajendran, Shruti S Desai, Joanna Gibson, Jassim DiPalermo, Michael Cecchini

J Immunother Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-daily oral icotrokinra versus placebo and once-daily oral deucravacitinib in participants with moderate-to-severe plaque psoriasis (ICONIC-ADVANCE 1 & 2): two phase 3, randomised, placebo-controlled and active-comparator-controlled trials.
Linda Stein Gold, April W Armstrong, Robert Bissonnette, Nina Magnolo, Ronald B Vender, Michael Cecchini

Lancet· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenomic Heterogeneity of Non-Functional Pancreatic Neuroendocrine Tumors Uncovered by Single nucleus and Spatial ATAC Profiling.
Dejiang Wang, Xiangjun Di, Fu Gao, Gaocai Li, Liyun Lin, Michael Cecchini

bioRxiv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Feasibility Study of Mass-Based Response Drug Screening to Guide Personalized Hyperthermic Intraperitoneal Chemotherapy for Appendiceal and Colorectal Adenocarcinoma with Peritoneal Metastasis.
Justin M Bader, Ava Ospina, Sean Liu, Biren Reddy, Princy Gupta, Michael Cecchini

Ann Surg Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Genomic Landscape of Late-Stage Gastric Cancer: Analysis From KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Studies.
Yelena Y Janjigian, Michael Cecchini, Kohei Shitara, Peter C Enzinger, Zev A Wainberg

JCO Precis Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Landscape of Late-Stage Gastric Cancer: Analysis From KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Studies.
Yelena Y Janjigian, Michael Cecchini, Kohei Shitara, Peter C Enzinger, Zev A Wainberg

JCO Precis Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olaparib in treatment-refractory isocitrate dehydrogenase 1 (IDH1)- and IDH2-mutant cholangiocarcinoma: Safety and antitumor activity from the phase 2 National Cancer Institute 10129 trial.
Michael Cecchini, Mary Jo Pilat, Nataliya Uboha, Nilofer S Azad, May Cho

Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular characteristics of advanced colorectal cancer and multi-hit PIK3CA mutations.
Faiza Yasin, Ethan Sokol, Neil Vasan, Dean C Pavlick, Richard S P Huang, Michael Cecchini

Oncologist· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology, treatment and outcomes of gastroenteropancreatic neuroendocrine neoplasms.
Johannes Uhlig, James Nie, Joanna Gibson, Michael Cecchini, Stacey Stein

Sci Rep· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of personalized and tumor-informed ctDNA with patient survival outcomes in pancreatic adenocarcinoma.
Gregory P Botta, Maen Abdelrahim, Ronald L Drengler, Vasily N Aushev, Abdullah Esmail, Michael Cecchini

Oncologist· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative Modified FOLFIRINOX for Resectable Pancreatic Cancer: A Nonrandomized Controlled Trial.
Michael Cecchini, Ronald R Salem, Marie Robert, Suzanne Czerniak, Ondrej Blaha

JAMA Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep-Transfer-Learning-Based Natural Language Processing of Serial Free-Text Computed Tomography Reports for Predicting Survival of Patients With Pancreatic Cancer.
Sunkyu Kim, Seung-Seob Kim, Eejung Kim, Michael Cecchini, Mi-Suk Park

JCO Clin Cancer Inform· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A single arm phase 2 clinical trial of YIV-906 with neoadjuvant concurrent chemo-radiation therapy in patients with locally advanced rectal cancer.
Nipun Verma, Kimberly L Johung, Jeremy Kortmansky, Wajih Zaheer, Jill Lacy, Michael Cecchini

J Gastrointest Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Mutational signature-based identification of DNA repair deficient gastroesophageal adenocarcinomas for therapeutic targeting.
Aurel Prosz, Pranshu Sahgal, Brandon M Huffman, Zsofia Sztupinszki, Clare X Morris, Michael Cecchini

NPJ Precis Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutational signature-based identification of DNA repair deficient gastroesophageal adenocarcinomas for therapeutic targeting.
Aurel Prosz, Pranshu Sahgal, Brandon M Huffman, Zsofia Sztupinszki, Clare X Morris, Michael Cecchini

NPJ Precis Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCI10066: a Phase 1/2 study of olaparib in combination with ramucirumab in previously treated metastatic gastric and gastroesophageal junction adenocarcinoma.
Michael Cecchini, James M Cleary, Yu Shyr, Joseph Chao, Nataliya Uboha

Br J Cancer· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relative Burden of Cancer and Noncancer Mortality Among Long-Term Survivors of Breast, Prostate, and Colorectal Cancer in the US.
Madhav Kc, Jane Fan, Terry Hyslop, Sirad Hassan, Michael Cecchini

JAMA Netw Open· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing a definition of immune exclusion in cancer: results of a modified Delphi workshop.
Guy Travis Clifton, Mace Rothenberg, Paolo Antonio Ascierto, Glenn Begley, Michael Cecchini

J Immunother Cancer· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCI 7977: A Phase I Dose-Escalation Study of Intermittent Oral ABT-888 (Veliparib) plus Intravenous Irinotecan Administered in Patients with Advanced Solid Tumors.
Michael Cecchini, Zenta Walther, Wei Wei, Navid Hafez, Mary Jo Pilat

Cancer Res Commun· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative DNA Repair Biomarkers and Immune Profiling for Temozolomide and Olaparib in Metastatic Colorectal Cancer.
Michael Cecchini, Janie Y Zhang, Wei Wei, Jeffrey Sklar, Jill Lacy

Cancer Res Commun· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-operative chemoradiotherapy with or without induction chemotherapy for operable locally-advanced esophageal cancer.
Gabrielle W Peters, Wesley Talcott, Nicholas V Peters, Andrew Dhanasopan, Jill Lacy, Michael Cecchini

J Gastrointest Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis